Clin2
NCT06752122Possibly a fitRecruiting

Safety study of RCS-21 in healthy volunteers

Healthy VolunteersSafetyTolerabilityPharmacokinetics

Part of Lungs & breathing clinical trials.

This study is testing a new inhaled drug called RCS-21 in healthy volunteers to see if it's safe and how the body handles it. You will be closely monitored and may receive either the drug or a placebo.

Summary written for real people, not researchers, by Clin2.

Phase
Phase 1
Enrollment
24 people
Ages
18 years to 64 years
Study type
Interventional

Who can take part

  • Be between 18 and 64 years old.
  • Be in good general health, with no major medical conditions.
  • Be a non-smoker or an ex-smoker who quit more than 5 years ago and smoked fewer than 10 pack-years total.
  • Have a body mass index (BMI) between 18.5 and 31.9.
  • Be able to use an inhaler properly.
  • If you are a woman who could become pregnant, agree to use highly effective birth control for the study period and avoid pregnancy and breastfeeding.

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT06532942Recruiting· Phase 1
Safety study of an inhaled drug in healthy adults

This study tests a new inhaled drug (MKND-201) in healthy volunteers to see if it's safe and how the body processes it. If you are a generally healthy adult between 40 and 65, you might be able to help researchers understand if this medicine is safe for future studies.

San Antonio, Texas
NCT07163182Recruiting· Phase 1
Safety study of nasal CHF6467 in healthy volunteers

This study tests a new medicine called CHF6467 given as a nasal spray. It looks at how safe the medicine is, how it is absorbed and removed from the body, and what side effects it might cause. Healthy volunteers aged 18 to 55 can take part.

Sofia
NCT07285967Not yet recruiting· Phase 1
Safety study of a new oral tablet in healthy volunteers

This early-phase study tests a new oral tablet (YR011) in healthy volunteers to see how safe it is and how the body processes it. It helps find the right dose for future studies.

NCT07463196Recruiting· Phase 1
Safety study of ACI-19764 in healthy adults

This trial tests a new oral medication, ACI-19764, in healthy adults to see how safe it is and how the body processes it. It may help researchers understand how the drug affects the immune system, which could lead to future treatments for certain conditions.

Groningen
NCT07510958Not yet recruiting· Phase 1
Testing an Inhaled Drug for Safety in Healthy Adults

This study tests an inhaled medication called SYH2059 to see how safe it is and how the body processes it. It is for healthy adults and involves taking the drug once or multiple times to measure its effects.

NCT07528703Not yet recruiting· Phase 1
Safety Study of RC010 Inhaled Powder in Healthy Adults

This is an early-stage safety study testing a new inhaled medication called RC010 in healthy volunteers. Researchers want to understand how safe it is, how well people tolerate it, and how the body processes it.

Beijing, Beijing Municipality

Hear when a new Healthy Volunteers trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.